This analysis, together with co-immunoprecipitation experiments, revealed that TMEM55B associates with TBC1D9B via a folded cysteine-rich domain starting from amino acid 65 (PDB: AF-Q86T03-F1-v4, AlphaFold), whereas the unstructured N-terminus of TMEM55B (i.e., amino acid residues 1365) was dispensable for binding (Supplementary Fig
This lawsuit is filed outside of the federal GLP-1 multidistrict litigation (MDL) pending in the Eastern District of Pennsylvania
Upcoming Investor Events Viking management will participate in the following upcoming investor events: William Blair 46 th Annual Growth Stock Conference Chicago, IL June 2 - 4, 2026 Jefferies Global Healthcare Conference New York, NY June 3 - 4, 2026 First Quarter 2026 Financial Highlights First Quarter ended March 31, 2026 and 2025 Research and development expenses were $150.2 million for the three months ended March 31, 2026, compared to $41.4 million for the same period in 2025
There's chronic inflammation, there's histamine issues, there's fibrosis and adhesions
